Identification of a novel role for sphingolipid signaling in TNFα and ischemic preconditioning mediated cardioprotection

Journal of Molecular and Cellular Cardiology

Volumn 34, Issue 5, 2002, Pages 509-518

  Lecour, Sandrine ^a,b,c   Smith, Robert M ^a,b,c   Woodward, Brian ^a,b,d   Opie, Lionel H ^a,b,c   Rochette, Luc ^a,b,c   Sack, Michael N ^a,b,c  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c UNIVERSITY OF BATH   (United Kingdom)

^d University of Bath   (United Kingdom)

Author keywords

C2 ceramide; Infarct size; N oleoylethanolamine; Sphingolipid signaling; TNF

Indexed keywords

5 HYDROXYDECANOIC ACID; CERAMIDE; ETHANOLAMINE DERIVATIVE; N OLEOYLETHANOLAMINE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SPHINGOLIPID; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; EXPERIMENTAL MODEL; HEART INFARCTION SIZE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0036586721     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2002.1533     Document Type: Article

References (39)

1. MURRY CE, JENNINGS RB, REIMER KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136.
2. NAKANO A, COHEN MV, DOWNEY JM. Ishcemic preconditioning: from basic mechanisms to clinical applications. Pharmacol Ther 2000; 86: 263-275.
3. BOLLI R. The late phase of preconditioning. Circ Res 2000; 87: 972-983.
4. EDDY LJ, GOEDDEL DV, WONG GH. Tumor necrosis factor-alpha pretreatment is protective in a rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun 1992; 184: 1056-1059.
5. NELSON SK, WONG GH, MCCORD JM. Leukemia inhibitory factor and tumor necrosis factor induce manganese superoxide dismutase and protect rabbit hearts from reperfusion injury. J Mol Cell Cardiol 1995; 27: 223-229.
6. YAMASHITA N, HOSHIDA S, OTSU K, ASAHI M, KUZUYA T, HORI M. Exercise provides direct biphasic cardioprotectton via manganese superoxide dismutase activation. J Exp Med 1999; 189: 1699-1706.
7. YAMASHITA N, HOSHIDA S, OTSU K, TANIGUCHI N, KUZUYA T, HORI M. The involvement of cytokines in the second window of ischaemic preconditioning. Br J Pharmacol 2000; 131: 415-422.
8. SMITH RM, SULEMAN N, MCCARTHY J, SACK MN. Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNF alpha gene. Cardiovasc Res; in press.
9. PERRY DK, HANNUM YA. The role of ceramide in cell signaling. Biochim Biophys Acta 1998; 1436: 233-243.
10. HANNUN YA. The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 1994; 269: 3125-3128.
11. XU J, YEH CH, CHEN S, HE L, SENSI SL, CANZONIERO LM, CHOI DW, HSU CY. Involvement of de novo ceramide biosynthesis in tumor necrosis factor alpha/cycloheximide-induced cerebral endothelial cell death. J Biol Chem 1998; 273: 16521-16526.
12. WANG YM, SEIBENHENER ML, VANDENPLAS ML, WOOTEN MW. Atypical PKC zeta is activated by ceramide, resulting in coactivation of NF-kappaB/ JNK kinase and cell survival. J Neurosci Res 1999; 55: 293-302.
13. SACK MN, SMITH RM, OPIE LH. Tumor necrosis factor in myocardial hypertrophy and ischaemia - an antiapoptotic perspective. Cardiovasc Res 2000; 45: 688-695.
14. LIU J, GINIS I, SPATZ M, HALLENBECK JM. Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-alpha and ceramide. Am J Physiol Cell Physiol 2000; 278: C144-C153.
15. ONO K, MATSUMORI A, SHIOI T, FURUKAWA Y, SASAMAYAMA S. Cytokine gene expression after myocardial infarction in rat hearts. Possible implication in left ventricular remodeling. Circulation 1998; 98: 149-156.
16. NOSSULI TO, LAKSHMINARAYANAN V, BAUMGARTEN G, TAFFET GE, BALLANTYNE CM, MICHAEL LH, ENTMAN ML. A chronic mouse model of myocardial ischemia-reperfusion: essential in cytokine studies. Am J Physiol Heart Circ Physiol 2000; 278: H1049-H1055.
17. YANG Z, ZINGARELLI B, SZABO C. Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury. Circulation 2000; 101: 1019-1026.
18. AWAN MM, TAUNYANE C, AITCHISON KA, YELLON DM, OPIE LH. Normothermic transfer times up to 3 min will not precondition the isolated rat heart. J Mol Cell Cardiol 1999; 31: 503-511.
19. EDMUNDS NJ, LAL H, WOODWARD B. Effects of tumour necrosis factor-alpha on left ventricular function in the rat isolated perfused heart: possible mechanisms for a decline in cardiac function. Br J Pharmacol 1999; 126: 189-196.
20. ORAL H, DORN GW 2ND, MANN DL. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian cardiac myocyte. J Biol Chem 1997; 272: 4836-4842.
21. GRANDEL U, FINK L, BLUM A, HEEP M, BUERKE M, KRAEMER HJ, MAYER K, BOHLE RM, SEEGER W, GRIMMINGER F, SIBELIUS U. Endotoxin-induced myocardial tumor necrosis factor-alpha synthesis depresses contractility of isolated rat hearts: evidence for a role of sphingosine and cyclooxygenase-2-derived thromboxane production. Circulation 2000; 102: 2758-2764.
22. JIN Z, ZHOU H, ZHU P, MOCHLY-ROSEN D, MESSING RO, GOETZL EJ, KARLINER JS, GRAY MO. Cardioprotection mediated by sphingosine-1-phosphate in epsilon PKC knockout mice. Circulation 2001; 104:II-209 (Abstract).
23. TAKANO H, TANG XL, BOLLI R. Differential role of K(ATP) channels in late preconditioning against myocardial stunning and infarction in rabbits. Am J Physiol Heart Circ Physiol 2000; 279: H2350-H2359.
24. AWAN MM, MAKAULA S, FORRESTI S, SACK MN, OPIE LH. Mechanisms whereby glucose deprivation triggers metabolic preconditioning in the isolated rat heart. Mol Cell Biochem 2000; 211: 111-121.
25. VANDEN HOEK TL, BECKER LB, SHAO Z, LI C, SCHUMACKER PT. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem 1998; 273: 18092-18098.
26. PAIN T, YANG XM, CRITZ SD, YUE Y, NAKANO A, LIU GS, HEUSCH G, COHEN MV, DOWNEY JM. Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res 2000; 87: 460-466.
27. LIU Y, O'ROURKE B. Opening of mitochondrial K(ATP) channels triggers cardioprotection. Are reactive oxygen species involved? Circ Res 2001; 88: 750-752.
28. LIU B, WHISLER RL. Transcriptional activation and redox regulation of the tumor necrosis factor-alpha promoter in human T cells: role of the CRE/kappa3 promoter region. J Interferon Cytokine Res 1998; 18: 999-1007.
29. JANSSEN-HEININGER YM, MACARA I, MOSSMAN BT. Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-kappaB: requirement of Ras/mitogen-activated protein kinases in the activation of NF-kappaB by oxidants. Am J Respir Cell Mol Biol 1999; 20: 942-952.
30. BELOSJOROW S, SCHULTZ R, DORGE H, SCHADE FU, HEUSCH C. Endotoxin and ischemic preconditioning: TNF-α concentration and myocardial infarct development in rabbits. Am J Physiol 1999; 277: H2470-H2475.
31. KURRELMEYER KM, MICHAEL LH, BAUMGARTEN G, TAFFET GE, PESCHON JJ, SIVASUBRAMANIAN N, ENTMAN ML, MANN DL. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci USA 2000; 97: 5456-5461.
32. SMITH RM, MCCARTHY J, SACK MN. TNF alpha is required for hypoxia-mediated right ventricular hypertrophy. Mol Cell Biochem 2001; 219: 139-143.
33. WADA H, SAITO K, KANDA T, KOBAYASHI I, FUJII H, FUJIGAKI S, MAEKAWA N, TAKATSU H, FUJIWARA H, SEKKAWA K, SEISHIMA M. Tumor necrosis factor-alpha (TNF-alpha) plays a protective role in acute viral myocarditis in mice: a study using mice lacking TNF-alpha. Circulation 2001; 103: 743-749.
34. SACK MN. TNFα in cardiovascular biology and the potential role for anti-TNFα therapy in heart disease. Pharmacol Therapeutics 2002; in press.
35. RAHMAN A, ANWAR KN, MALIK AB. Protein kinase C-zeta mediates TNF-alpha-induced ICAM-1 gene transcription in endothelial cells. Am J Physiol Cell Physiol 2000; 279: C906-C914.
36. VANCUROVA I, MISKOLCI V, DAVIDSON D. NF-kappa B activation in tumor necrosis factor alpha-stimulated neutrophils is mediated by protein kinase C-delta. Correlation to nuclear I-kappa B-alpha. J Biol Chem 2001; 276: 19746-19752.
37. GINIS I, SCHWEIZER U, BRENNER M, LIU J, AZZAM N, SPATZ M, HALLENBECK JM. TNF-alpha pretreatment prevents subsequent activation of cultured brain cells with TNF-alpha and hypoxia via ceramide. Am J Physiol 1999; 276: C1171-C1183.
38. ZHOU H, SUMMERS SA, BIRNBAUM MJ, PITTMAN RN. Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis. J Biol Chem 1998; 273: 16568-16575.
39. MINNERS J, LACERDA L, MCCARTHY M, MEIRING JJ, YELLON DM, SACK MN. Ischemic and pharmacologic preconditioning in girardi cells and C2-C12 myotubes induce mitochondrial uncoupling. Circ Res 2001; 89: 787-792.